Technical Analysis for SBIO - ALPS Medical Breakthroughs ETF
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Historical SBIO trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Gapped Up | Strength | 0.00% | |
| MACD Bearish Centerline Cross | Bearish | 2.28% | |
| Lower Bollinger Band Walk | Weakness | 2.28% | |
| Below Lower BB | Weakness | 2.28% | |
| Down 3 Days in a Row | Weakness | 2.28% | |
| Lower Bollinger Band Touch | Weakness | 2.28% | |
| Fell Below 50 DMA | Bearish | 0.92% | |
| Expansion Pivot Sell Setup | Bearish Swing Setup | 0.92% | |
| Multiple of Ten Bullish | Other | 0.92% | |
| Lower Bollinger Band Touch | Weakness | 0.92% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM.
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.
Index Fund Biotechnology Pharmaceutical Passive Management
Index Fund Biotechnology Pharmaceutical Passive Management
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 43.96 |
| 52 Week Low | 30.1401 |
| Average Volume | 58,370 |
| 200-Day Moving Average | 36.04 |
| 50-Day Moving Average | 40.82 |
| 20-Day Moving Average | 41.32 |
| 10-Day Moving Average | 41.26 |
| Average True Range | 0.96 |
| ADX | 24.3 |
| +DI | 23.39 |
| -DI | 37.40 |
| Chandelier Exit (Long, 3 ATRs ) | 41.07 |
| Chandelier Exit (Short, 3 ATRs ) | 41.57 |
| Upper Bollinger Band | 42.86 |
| Lower Bollinger Band | 39.79 |
| Percent B (%b) | 0.22 |
| BandWidth | 7.43 |
| MACD Line | -0.14 |
| MACD Signal Line | 0.14 |
| MACD Histogram | -0.2813 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 41.31 | ||||
| Resistance 3 (R3) | 41.33 | 41.06 | 41.16 | ||
| Resistance 2 (R2) | 41.06 | 40.85 | 41.05 | 41.12 | |
| Resistance 1 (R1) | 40.76 | 40.71 | 40.91 | 40.74 | 41.07 |
| Pivot Point | 40.49 | 40.49 | 40.57 | 40.48 | 40.49 |
| Support 1 (S1) | 40.19 | 40.28 | 40.34 | 40.16 | 39.83 |
| Support 2 (S2) | 39.92 | 40.14 | 39.91 | 39.78 | |
| Support 3 (S3) | 39.62 | 39.92 | 39.74 | ||
| Support 4 (S4) | 39.59 |
